Filing Details
- Accession Number:
- 0000899243-21-024984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-21 16:26:46
- Reporting Period:
- 2021-06-18
- Accepted Time:
- 2021-06-21 16:26:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651431 | Checkmate Pharmaceuticals Inc. | CMPI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1335659 | M Arthur Krieg | C/O Checkmate Pharmaceuticals, Inc. 245 Main Street, 2Nd Floor Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-18 | 7,224 | $6.04 | 815,734 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
